• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激在心力衰竭前期 B 期疾病进展中的作用。

Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

机构信息

Methodist DeBakey Cardiology Associates, Smith Tower, 6550 Fannin, Suite 1901, Houston, TX 77030, USA.

出版信息

Heart Fail Clin. 2012 Jan;8(1):101-11. doi: 10.1016/j.hfc.2011.08.003. Epub 2011 Oct 22.

DOI:10.1016/j.hfc.2011.08.003
PMID:22108730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3227012/
Abstract

Oxidative stress represents a persistent imbalance between the production and the compensation of reactive oxygen species. Though predominantly found in advanced heart failure, the most frequent "at-risk" condition has been associated with underlying oxidative stress. It is therefore conceivable that timely detection and early intervention to reduce oxidative stress processes provide an opportunity to prevent disease progression to overt heart failure. This article reviews the current understanding of the current evidence of oxidative stress involvement in the pathophysiology of human heart failure and its potential therapeutic interventions in patients with Stage A and B heart failure.

摘要

氧化应激代表活性氧产生与补偿之间的持续失衡。尽管主要存在于晚期心力衰竭中,但最常见的“高危”情况与潜在的氧化应激有关。因此,可以想象,及时发现和早期干预以减少氧化应激过程,为预防疾病进展为明显心力衰竭提供了机会。本文综述了当前对氧化应激在人类心力衰竭病理生理学中的作用及其在 A 期和 B 期心力衰竭患者中的潜在治疗干预的理解。

相似文献

1
Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.氧化应激在心力衰竭前期 B 期疾病进展中的作用。
Heart Fail Clin. 2012 Jan;8(1):101-11. doi: 10.1016/j.hfc.2011.08.003. Epub 2011 Oct 22.
2
Treating oxidative stress in heart failure: past, present and future.心力衰竭中氧化应激的治疗:过去、现在和未来。
Eur J Heart Fail. 2019 Apr;21(4):425-435. doi: 10.1002/ejhf.1320. Epub 2018 Oct 19.
3
Pharmacologic strategies to target oxidative stress in heart failure.针对心力衰竭中氧化应激的药理学策略。
Curr Heart Fail Rep. 2012 Mar;9(1):14-22. doi: 10.1007/s11897-011-0081-5.
4
Novel aspects of ROS signalling in heart failure.ROS 信号在心力衰竭中的新方面。
Basic Res Cardiol. 2013 Jul;108(4):359. doi: 10.1007/s00395-013-0359-8. Epub 2013 Jun 6.
5
Oxidative stress in heart failure: what are we missing?心力衰竭中的氧化应激:我们遗漏了什么?
Am J Med Sci. 2011 Aug;342(2):120-4. doi: 10.1097/MAJ.0b013e3182249fcd.
6
Oxidative stress and heart failure.氧化应激与心力衰竭
Coron Artery Dis. 2003 Apr;14(2):109-13. doi: 10.1097/00019501-200304000-00003.
7
The nitric oxide pathway and oxidative stress in heart failure.心力衰竭中的一氧化氮途径与氧化应激
Congest Heart Fail. 2002 May-Jun;8(3):142-7, 155. doi: 10.1111/j.1527-5299.2002.00715.x.
8
Uncoupling proteins in heart failure.心力衰竭中的解偶联蛋白
Curr Heart Fail Rep. 2008 Jun;5(2):75-9. doi: 10.1007/s11897-008-0013-1.
9
Heart failure: mitochondrial dysfunction and oxidative stress in CHF.心力衰竭:慢性心力衰竭中的线粒体功能障碍与氧化应激
Nat Rev Cardiol. 2015 Jan;12(1):6-8. doi: 10.1038/nrcardio.2014.189. Epub 2014 Nov 25.
10
Redox-sensitive mechanisms underlying vascular dysfunction in heart failure.心力衰竭中血管功能障碍的氧化还原敏感机制。
Free Radic Res. 2015 Jun;49(6):721-42. doi: 10.3109/10715762.2015.1027200. Epub 2015 Apr 25.

引用本文的文献

1
Chemical Properties, Preparation, and Pharmaceutical Effects of Cyclic Peptides from .来自……的环肽的化学性质、制备方法及药学作用
Molecules. 2025 Jun 9;30(12):2521. doi: 10.3390/molecules30122521.
2
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.异甘草素作为Nrf2信号通路的调节剂:潜在的治疗意义。
Front Pharmacol. 2024 Oct 9;15:1395735. doi: 10.3389/fphar.2024.1395735. eCollection 2024.
3
Prevention of Heart Failure in Patients with Chronic Kidney Disease.慢性肾脏病患者心力衰竭的预防

本文引用的文献

1
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.评估非 ST 段抬高急性冠状动脉综合征中的多种心脏生物标志物:MERLIN-TIMI 36 试验观察结果。
Eur Heart J. 2011 Mar;32(6):697-705. doi: 10.1093/eurheartj/ehq468. Epub 2010 Dec 22.
2
Mitochondria-targeted cardioprotection in aldosteronism.靶向线粒体的醛固酮症心肌保护作用。
J Cardiovasc Pharmacol. 2011 Jan;57(1):37-43. doi: 10.1097/FJC.0b013e3181fe1250.
3
Effect of serum insulin on the association between hyperuricemia and incident heart failure.
Curr Cardiovasc Risk Rep. 2015 Jan;9(1). doi: 10.1007/s12170-014-0428-z.
4
Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.细胞外囊泡通过 Nrf2 调控心力衰竭中的交感兴奋。
Circ Res. 2022 Sep 30;131(8):687-700. doi: 10.1161/CIRCRESAHA.122.320916. Epub 2022 Sep 13.
5
Butein Inhibits Oxidative Stress Injury in Rats with Chronic Heart Failure via ERK/Nrf2 Signaling.白杨素通过 ERK/Nrf2 信号通路抑制慢性心力衰竭大鼠的氧化应激损伤。
Cardiovasc Ther. 2022 Jan 4;2022:8684014. doi: 10.1155/2022/8684014. eCollection 2022.
6
Role of iron homeostasis in the heart : Heart failure, cardiomyopathy, and ischemia-reperfusion injury.铁稳态在心脏中的作用:心力衰竭、心肌病和缺血再灌注损伤。
Herz. 2022 Apr;47(2):141-149. doi: 10.1007/s00059-021-05039-w. Epub 2021 May 12.
7
Polysaccharides from Hemp Seed Protect against Cyclophosphamide-Induced Intestinal Oxidative Damage via Nrf2-Keap1 Signaling Pathway in Mice.麻籽油多糖通过 Nrf2-Keap1 信号通路对环磷酰胺诱导的小鼠肠道氧化损伤的保护作用。
Oxid Med Cell Longev. 2020 Aug 25;2020:1813798. doi: 10.1155/2020/1813798. eCollection 2020.
8
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.Bardoxolone 甲酯对慢性心力衰竭中 Nrf2 激活的治疗作用。
J Pharmacol Exp Ther. 2019 Dec;371(3):642-651. doi: 10.1124/jpet.119.261792. Epub 2019 Oct 10.
9
Oxygen: how do we stand it?氧气:我们如何忍受它?
Med Princ Pract. 2013;22(2):131-7. doi: 10.1159/000339212. Epub 2012 Jun 28.
血清胰岛素对高尿酸血症与心力衰竭事件相关性的影响。
Am J Cardiol. 2010 Oct 15;106(8):1134-8. doi: 10.1016/j.amjcard.2010.06.023.
4
Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".醛固酮通过“非基因组效应”加速射血分数保留的心力衰竭的进展。
Circulation. 2010 Jul 27;122(4):370-8. doi: 10.1161/CIRCULATIONAHA.109.915215. Epub 2010 Jul 12.
5
Statin treatment for patients with heart failure.他汀类药物治疗心力衰竭患者。
Nat Rev Cardiol. 2010 May;7(5):249-55. doi: 10.1038/nrcardio.2010.29. Epub 2010 Mar 16.
6
Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%.在慢性孤立性二尖瓣反流和射血分数>60%的患者中,氧化应激增加和心肌细胞肌原纤维变性。
J Am Coll Cardiol. 2010 Feb 16;55(7):671-9. doi: 10.1016/j.jacc.2009.08.074.
7
The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.基于人群的研究:糖尿病患者和临床前期舒张功能障碍患者中心力衰竭的发展。
J Am Coll Cardiol. 2010 Jan 26;55(4):300-5. doi: 10.1016/j.jacc.2009.12.003.
8
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.中枢神经系统中超氧化物歧化酶减少诱导高血压和外周炎症。
Hypertension. 2010 Feb;55(2):277-83, 6p following 283. doi: 10.1161/HYPERTENSIONAHA.109.142646. Epub 2009 Dec 14.
9
Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.他汀类药物与安慰剂治疗心力衰竭患者的随机对照试验的荟萃分析。
Am J Cardiol. 2009 Dec 15;104(12):1708-16. doi: 10.1016/j.amjcard.2009.07.055.
10
Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II.Nox2和Nox4的基因沉默揭示了这些NADPH氧化酶同系物在脑源性血管紧张素II的升压和致渴作用中的不同作用。
Hypertension. 2009 Nov;54(5):1106-14. doi: 10.1161/HYPERTENSIONAHA.109.140087. Epub 2009 Oct 5.